Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • ADCETRIS (Millenium C25003)

    A Randomized Open-label Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

    View Trial
  • Caring for people with bowel cancer recurrence

    View Trial
  • The metabolic effects of DNA epimutations in Growth Disorders

    View Trial
  • YES-P

    A prospective randomized clinical trial on 90Yttrium trans-arterial radio-Embolization (TheraSphere) vs. standard of care (sorafenib) for the treatment of advanced Hepatocellular carcinoma (Hcc) with Portal Vein Thrombosis (PVT)

    View Trial
  • Azithromycin for the treatment of PID

    Is a short course of azithromycin effective in the treatment of mild to moderate pelvic inflammatory disease (PID)?

    View Trial
  • Supplemental Evaluation of Cancer Antigen Expression in Patients

    View Trial
  • Defining Immune Tolerance in Anti-Neutrophill Cytoplasm Antibody (ANCA) associated systemic vasculitis (AVATARS)

    View Trial
  • Investigation of genetic and serologic factors influencing drug induced pneumonitis in disease modifying anti-rheumatic drug (DMARD) treated rheumatoid arthritis patients

    View Trial
  • Development and Implementation of Positive Voices: the National Survey of People Living with HIV

    View Trial
  • ROMAZA

    ROMAZA: Phase I trial of combination therapy with romidepsin and azacitidine in patients with newly diagnosed relapsed or refractory Acute Myeloid Leukaemia ineligible for conventional chemotherapy

    View Trial